| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.04B | 32.69B | 24.83B | 20.30B | 13.58B | 10.35B |
| Gross Profit | 6.73B | 10.19B | 8.06B | 6.00B | 3.85B | 3.24B |
| EBITDA | 4.88B | 7.67B | 6.24B | 4.44B | 2.85B | 2.67B |
| Net Income | 3.64B | 5.73B | 4.44B | 3.14B | 2.00B | 1.91B |
Balance Sheet | ||||||
| Total Assets | 27.29B | 30.81B | 19.78B | 14.59B | 9.95B | 7.32B |
| Cash, Cash Equivalents and Short-Term Investments | 14.87B | 17.33B | 9.13B | 6.38B | 4.63B | 3.58B |
| Total Debt | 111.11M | 187.34M | 92.55M | 386.17M | 281.64M | 142.76M |
| Total Liabilities | 5.91B | 6.03B | 4.72B | 4.00B | 2.47B | 1.77B |
| Stockholders Equity | 21.25B | 24.46B | 14.96B | 10.51B | 7.45B | 5.54B |
Cash Flow | ||||||
| Free Cash Flow | 3.63B | 5.35B | 4.56B | 2.10B | 1.17B | 740.02M |
| Operating Cash Flow | 4.18B | 6.04B | 6.01B | 3.79B | 2.43B | 1.69B |
| Investing Cash Flow | -5.27B | -6.36B | -7.02B | -825.34M | -2.20B | -1.83B |
| Financing Cash Flow | 3.56B | 3.51B | -277.44M | -111.32M | -139.26M | 726.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$527.68B | 30.61 | 42.43% | 1.73% | 22.57% | 31.01% | |
74 Outperform | HK$10.24B | 12.99 | 12.69% | 3.62% | 2.61% | -0.12% | |
73 Outperform | HK$110.39B | 24.14 | 20.39% | ― | ― | ― | |
71 Outperform | HK$32.05B | 15.79 | 15.41% | 5.64% | 4.51% | 10.64% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$21.03B | 22.58 | ― | 6.30% | ― | ― | |
54 Neutral | HK$239.42M | -19.23 | -6.67% | ― | -3.29% | -22.01% |